These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 34412980
21. QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis. Sotgiu G, Saderi L, Petruccioli E, Aliberti S, Piana A, Petrone L, Goletti D. J Infect; 2019 Nov; 79(5):444-453. PubMed ID: 31473271 [Abstract] [Full Text] [Related]
22. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM. Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280 [Abstract] [Full Text] [Related]
23. Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa. Ntshiqa T, Chihota V, Mansukhani R, Nhlangulela L, Velen K, Charalambous S, Maenetje P, Hawn TR, Wallis R, Grant AD, Fielding K, Churchyard G. Gates Open Res; 2021 Nov; 5():66. PubMed ID: 37560544 [Abstract] [Full Text] [Related]
24. Comparing the Diagnostic Performance of QuantiFERON-TB Gold Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D. Clin Infect Dis; 2021 Sep 07; 73(5):e1116-e1125. PubMed ID: 33289038 [Abstract] [Full Text] [Related]
25. Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. Hong JY, Park SY, Kim A, Cho SN, Hur YG. J Thorac Dis; 2019 Dec 07; 11(12):5210-5217. PubMed ID: 32030238 [Abstract] [Full Text] [Related]
26. [Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In Tube in the diagnosis of pulmonary tuberculosis]. Wang XY, Su BY, Chen ZY, Kuang HB, Guan P, Cao ZZ, Tan YJ. Zhonghua Jie He He Hu Xi Za Zhi; 2022 May 12; 45(5):445-452. PubMed ID: 35527459 [Abstract] [Full Text] [Related]
27. Clinical evaluation of QuantiFERON®-TB Gold Plus directly compared with QuantiFERON®-TB Gold In-Tube and T-Spot®.TB for active pulmonary tuberculosis in the elderly. Fukushima K, Kubo T, Akagi K, Miyashita R, Kondo A, Ehara N, Takazono T, Sakamoto N, Mukae H. J Infect Chemother; 2021 Dec 12; 27(12):1716-1722. PubMed ID: 34412981 [Abstract] [Full Text] [Related]
28. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status. Tang J, Huang Y, Jiang S, Huang F, Ma T, Qi Y, Ma Y. Tuberculosis (Edinb); 2020 Sep 12; 124():101966. PubMed ID: 32866942 [Abstract] [Full Text] [Related]
29. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study. Pérez-Recio S, Pallarès N, Grijota-Camino MD, Sánchez-Montalvá A, Barcia L, Campos-Gutiérrez S, Pomar V, Rabuñal-Rey R, Balcells ME, Gazel D, Montiel N, Vicente D, Goić-Barišić I, Schön T, Paues J, Mareković I, Cacho-Calvo J, Barac A, Goletti D, García-Gasalla M, Barcala JM, Tórtola MT, Anibarro L, Suárez-Toste I, Moga E, Gude-Gonzalez MJ, Naves R, Karslıgil T, Martin-Peñaranda T, Stevanovic G, Trigo M, Rubio V, Karaoğlan İ, Bayram N, Alcaide F, Tebé C, Santin M, ESCMID Study Group for Mycobacterial Infections (ESGMYC) and the Mycobacteria Study Group (GEIM) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Microbiol Spectr; 2021 Dec 22; 9(3):e0097221. PubMed ID: 34756079 [Abstract] [Full Text] [Related]
30. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Petrone L, Vanini V, Chiacchio T, Petruccioli E, Cuzzi G, Schininà V, Palmieri F, Ippolito G, Goletti D. Tuberculosis (Edinb); 2018 Jul 22; 111():147-153. PubMed ID: 30029901 [Abstract] [Full Text] [Related]
31. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation. Takwoingi Y, Whitworth H, Rees-Roberts M, Badhan A, Partlett C, Green N, Boakye A, Lambie H, Marongiu L, Jit M, White P, Deeks JJ, Kon OM, Lalvani A. Health Technol Assess; 2019 May 22; 23(23):1-152. PubMed ID: 31138395 [Abstract] [Full Text] [Related]
32. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT]. Matsumoto T, Yamazaki T. Kekkaku; 2014 Sep 22; 89(9):743-55. PubMed ID: 25730946 [Abstract] [Full Text] [Related]
33. Comparison of interferon-gamma production between TB1 and TB2 tubes of QuantiFERON-TB Gold Plus: a meta-analysis. Darmawan G, Liman LMS, Hamijoyo L, Atik N, Alisjahbana B, Sahiratmadja E. Clin Chem Lab Med; 2023 Nov 27; 61(12):2067-2075. PubMed ID: 37221870 [Abstract] [Full Text] [Related]
34. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation. Auguste P, Tsertsvadze A, Pink J, Court R, Seedat F, Gurung T, Freeman K, Taylor-Phillips S, Walker C, Madan J, Kandala NB, Clarke A, Sutcliffe P. Health Technol Assess; 2016 May 27; 20(38):1-678. PubMed ID: 27220068 [Abstract] [Full Text] [Related]